Literature DB >> 20831525

Letter: HLA B*1502 allele association with oxcarbamazepine-induced skin reactions in epilepsy patient from India.

Umapathy Shankarkumar, Krishnakumar N Shah, Kanjaksha Ghosh.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 20831525     DOI： 10.1111/j.1528-1167.2009.02096.x

Source DB:  PubMed          Journal:  Epilepsia        ISSN： 0013-9580            Impact factor:   5.864


× No keyword cloud information.
  3 in total

1.  Clinical Pharmacogenetics Implementation Consortium guidelines for HLA-B genotype and carbamazepine dosing.

Authors:  S G Leckband; J R Kelsoe; H M Dunnenberger; A L George; E Tran; R Berger; D J Müller; M Whirl-Carrillo; K E Caudle; M Pirmohamed
Journal:  Clin Pharmacol Ther       Date:  2013-05-21       Impact factor: 6.875

2.  Clinical pharmacogenetics implementation consortium guidelines for CYP2C9 and HLA-B genotypes and phenytoin dosing.

Authors:  K E Caudle; A E Rettie; M Whirl-Carrillo; L H Smith; S Mintzer; M T M Lee; T E Klein; J T Callaghan
Journal:  Clin Pharmacol Ther       Date:  2014-08-06       Impact factor: 6.875

3.  The association between oxcarbazepine-induced maculopapular eruption and HLA-B alleles in a northern Han Chinese population.

Authors:  Yu-Dan Lv; Fu-Li Min; Wei-Ping Liao; Na He; Tao Zeng; Di-Hui Ma; Yi-Wu Shi
Journal:  BMC Neurol       Date:  2013-07-08       Impact factor: 2.474
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.